NORTHAMPTON, Mass. — CONTINUE week, Sprout Pharmaceuticals resubmitted its medication flibanserin into the Food and Drug management for approval. Flibanserin, when you haven’t heard, is a medication meant to treat low libido in females. The F.D.A. has refused it twice currently, and can most likely reject it a 3rd time because (if you’re Sprout) the F.D.A. is sexist or (if you’re the F.D.A.) the medication does not work and it isn’t safe.
However the problem that is biggest because of the medication — along with the F.D.A.’s consideration from it — is the fact that its backers are trying to treat a thing that is not an ailment.
Flibanserin purportedly treats an ailment called hypoactive desire that is sexual in females. But H.S.D.D. ended up being taken from the United states Psychiatric Association’s Diagnostic and Statistical handbook of Mental Disorders in 2013, and replaced having a brand new diagnosis called female sexual interest/arousal condition, or F.S.I.A.D. Continue reading “There Is Nothing Incorrect Along With Your Libido”